The pharmaceutical distribution companies stating “No exception for Japanese pharmaceutical companies”

It was known that some Japanese pharmaceutical companies branched in Korea are providing lower distribution cost than the break-even point for wholesales companies.

Accordingly, the pharmaceutical distribution industry, after settling the distribution cost conflicts against multinational pharmaceutical companies including Pfizer Korea, is planning to actualize distribution cost against Japanes...